Business
from24/7 Wall St.
5 days agoTeledoc (TDOC) Gets a $7 Price Target From Barclays: Can It Double From Recent Lows?
Teladoc Health's stock shows short-term recovery but remains significantly down over the long term, with analysts maintaining cautious outlooks.